Becton, Dickinson and Company

BDX · NYSE · Stock · Healthcare
$187.61
+0.13% today
Delayed price,

What Becton, Dickinson and does

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Key facts

Sector
Healthcare
Industry
Medical Instruments & Supplies
Market cap
$51.10B
P/E (ttm)
43.6
Forward P/E
14.1
Dividend yield
2.24%
Beta
0.28
Profit margin
4.2%
Employees
72,000
Headquarters
Franklin Lakes, NJ, United States
Exchange
NYSE
Website

Performance

1 Month
+3.7%
3 Months
+18.6%
6 Months
+18.3%
1 Year
+26.2%
5 Years
+3.1%
$127.5952-week range$193.07
Biggest setback — last 12 months
-22.6%
16 Feb 2026 → 11 May 2026
Fell from $185.39 to $143.47 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+37.3%
3 Nov 2025 → 17 Aug 2026
Ran from $139.81 to $192.00 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$174.42 (-7.0%)$187.61$201.80 (+7.6%)
3 Months$165.35 (-11.9%)$187.61$212.86 (+13.5%)
6 Months$156.92 (-16.4%)$187.61$224.30 (+19.6%)
12 Months$145.74 (-22.3%)$187.61$241.52 (+28.7%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 25.3%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.